-
Mashup Score: 6Ischaemic stroke in atrial fibrillation patients while on oral anticoagulation—a call for A-C-T-I-O-N - 11 month(s) ago
This editorial refers to ‘Outcomes of patients with atrial fibrillation and ischaemic stroke while on oral anticoagulation’, by A. P. Benz et al., https://doi.o
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1ESC 2022 Late-breaker Discussion: The INVICTUS Trial - 1 year(s) ago
Watch on Radcliffe Cardiology: https://www.aerjournal.com/video-index/esc-22-late-breaker-discussion-invictus-trial?_ga=2.176523746.670019713.1661586894-1157…
Source: YouTubeCategories: Cardiologists, Latest HeadlinesTweet-
@Hragy @PHRIresearch @HEI_mcmaster Adherence to treatment was much lower in the rivaroxaban than #VKA group. But there are many interesting findings in this trial - including lower SCD & pump failure death in VKA group - that I’m sure it will be discussed during GR. A shorter synopsis: https://t.co/n9rKJ6NdKu
-
-
Mashup Score: 4
The use of warfarin in patients with atrial fibrillation (AF) and end-stage renal disease (ESRD) has been implicated with efficacy and safety concerns…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
#DOAC #VKA in ESRD #MA by @fischman_david et al https://t.co/rIEokIDIf1
-
-
Mashup Score: 5
Objectives To assess cost-effectiveness of direct oral anticoagulants (DOACs) compared with vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF) by pooling incremental net benefits (INBs). Design Systematic review and meta-analysis. Setting We searched PubMed, Scopus and Centre for Evaluation of Value and Risks in Health Registry from inception to December…
Source: BMJ Evidence-Based MedicineCategories: Latest Headlines, PayerTweet-
Economic evaluation of direct oral anticoagulants versus vitamin K antagonists for atrial fibrillation - a systematic review and metaanalysis by Noviyani and colleagues. #OpenAccess #Afib #VKA #DOAC ▶️https://t.co/fakgUKCiVW https://t.co/X1IAdOISoE
-
-
Mashup Score: 6
AbstractAim. Current guidelines recommend the use of vitamin K antagonist (VKA) for up to 3–6 months for treatment of left ventricular (LV) thrombus post-acute
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
#DOAC vs #VKA (warfarin) in patients with LV thrombus after #MI https://t.co/QbZrbZbHO6
-
-
Mashup Score: 1Prosthetic heart valves: Part 2 - Antithrombotic management - 3 year(s) ago
Your access to the latest cardiovascular news, science, tools and resources.
Source: www.escardio.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#Mechanical #ProstheticHeartValve needs #VKA therapy while #bioprosthesis allows a different strategy. In #TAVR chronic single or dual antiplatelet therapy is recommended. A summary presented in #CVPracticeJournal https://t.co/YV2dfDWV1k #cardiotwitter @PPibarot @StefanoNistri https://t.co/10dir72Z0O
-
-
Mashup Score: 1Direct oral anticoagulant use and outcomes in adult patients with Fontan circulation: A multicenter retrospective cohort study - PubMed - 3 year(s) ago
DOAC may be a safe antithrombotic agent for use in adult patients with Fontan circulation, particularly in males. However, these findings should be confirmed in multi-institutional prospective studies.
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
And the debate goes on. I know I use #DOAC in #Fontan with atrial arrhythmias. HRS guidelines need refreshing. Likely safe here and (possibly) superior to #VKA? When does UNIVERSE come out? @mgoschu @ShelbyKuttyMD @sasha_opo @AlexFrogoudaki @ACTION4HF https://t.co/dokVXSE3TP
-
-
Mashup Score: 3Meta-Analysis Investigating the Role of Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi - 3 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2021 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.ScienceDirect ® is a registered…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
#MetaAAnalysis Role of #DOAC vs #VKA in LV thrombus https://t.co/kvVTzClkxl
-
-
Mashup Score: 2Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease - 3 year(s) ago
AbstractAims. There are scarce data evaluating the effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation (NVAF) patients with
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Effectiveness and safety of #rivaroxaban vs. #VKA in patients with #AF and #PAD or #CAD | European Heart Journal - Cardiovascular Pharmacotherapy https://t.co/vXKydzvAvC
-
-
Mashup Score: 1Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review - 3 year(s) ago
Abstract Endothelial injury and microvascular/macrovascular thrombosis are common pathophysiological features of coronavirus disease-2019 (COVID-19). However, the optimal thromboprophylactic regime…
Categories: Cardiologists, Latest HeadlinesTweet-
Very Intrigued by this State-of-Art Review on #RCTs of #Antithrombotic Therapy in #Covid19 Would be #NOAC equivalent to #VKA or to #Heparin in #Covid19? @ACCinTouch @JACCJournals @SABOURETCardio @DocSavageTJU @DrMarthaGulati @mmamas1973 @DBelardoMD https://t.co/Si3vXuInrO https://t.co/5BYEIUcwcm
-
Ischaemic stroke in atrial fibrillation patients while on oral anticoagulation: a call for A-C-T-I-O-N. Read more in #EHJ: https://t.co/9bAo7pTyix #AF #stroke #anticoagulation #OAC #VKA #DOACS #cardiotwitter @escardio @ESC_Journals https://t.co/CuscgJ03wB